Laboratory Corporation of America Holdings announced the expanded availability of its proprietary specimen collection and handling software, LabCorpAccuDraw. Combining on-screen visual cues with step-by-step tutorials, AccuDraw is an innovative tool designed to guide the health care professional who collects patient specimens throughout the specimen collection process. AccuDraw helps to facilitate collection and appropriate stabilization of the correct specimen type and sample volume.

This technology-enabled solution leads to fewer errors in specimen collection and processing, a reduced chance of delays in testing, and a lower likelihood of having a patient undergo a second visit to a health care professional for further specimen collection. AccuDraw has been used in LabCorp's patient service centers and by LabCorp's phlebotomists located in client locations for over five years. AccuDraw has previously only been, and will continue to be, available to LabCorp clients through the LabCorp Beacon application.

AccuDraw provides a detailed set of specimen collection and handling instructions, allowing office staff to spend more time on patient care and less time confirming the specimen collection process and requirements. On-screen visual cues are combined with detailed collection instructions to help ensure specimen and collection accuracy in the physician office. For patients and the physician office, AccuDraw provides: Improved precision and accuracy – Visual cues are customized to the specific physician test order and linked to LabCorp's current test requirements.

High-quality specimens – the guided process and clear instructions helps to ensure the quality specimen is sent to the laboratory for testing. Time efficiencies – Reduce the amount of time spent speaking to the lab about specimen requirements or identifying specimens that were not properly submitted to the lab. Reduction in repeat draws – AccuDraw's collection, handling, and shipping guidance significantly reduces the need for patient redraws and repeat visits.